Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors

Published:2019-03-04 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Rapisuwon Suthee^ORCID,Izar Benjamin,Batenchuk Cory,Avila Alexandre,Mei Shaolin,Sorger Peter,Parks Jerry M.,Cooper Sarah J.,Wagner David,Zeck Jay C.,Charabaty Aline J.,Atkins Michael B.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0533-0.pdf

Reference25 articles.

1. Inskip PD, Devesa SS, Fraumeni JF Jr. Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control. 2003;14:251–7.

2. Cancer Genome Atlas N. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681–96.

3. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56–61.

4. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, et al. Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373:23–34.

5. Algazi AP, Tsai KK, Shoushtari AN, Munhoz RR, Eroglu Z, Piulats JM, Ott PA, Johnson DB, Hwang J, Daud AI, et al. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Cancer. 2016;122:3344–53.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy;Frontiers in Immunology;2023-08-23

2. Challenges in posterior uveitis—tips and tricks for the retina specialist;Journal of Ophthalmic Inflammation and Infection;2023-08-17

3. Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database;Cutaneous and Ocular Toxicology;2023-04-03

4. Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab;Ophthalmic Surgery, Lasers and Imaging Retina;2023-03

5. Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors;Journal for ImmunoTherapy of Cancer;2023-03